GSA Capital Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.96M	Sell	557,085 -315,900	-36%	-$1.01M	0.12%	180
2025 Q4	$2.38M	Buy	872,985 +793,763	+1,002%	+$1.84M	0.21%	45
2025 Q3	$172K	Sell	79,222 -117,385	-60%	-$277K	0.01%	1462
2025 Q2	$338K	Buy	196,607 +170,680	+658%	+$425K	0.02%	1185
2025 Q1	$86K	Buy	+25,927	New	+$134K	0.01%	1517
2024 Q4	–	Sell	-25,824	Closed	-$242K	–	1803
2024 Q3	$242K	Buy	+25,824	New	+$245K	0.02%	1334
2024 Q2	–	Sell	-61,225	Closed	-$907K	–	1825
2024 Q1	$907K	Buy	+61,225	New	+$713K	0.07%	502
2023 Q2	–	Sell	-216,782	Closed	-$1.32M	–	1716
2023 Q1	$1.32M	Buy	216,782 +40,989	+23%	+$283K	0.13%	188
2022 Q4	$1.12M	Buy	175,793 +95,017	+118%	+$742K	0.14%	165
2022 Q3	$774K	Sell	80,776 -97,802	-55%	-$1.13M	0.1%	284
2022 Q2	$1.97M	Buy	178,578 +161,755	+962%	+$2.12M	0.3%	13
2022 Q1	$280K	Buy	16,823 +1,425	+9%	+$22K	0.04%	944
2021 Q4	$294K	Buy	+15,398	New	+$339K	0.04%	946
2021 Q1	–	Sell	-5,321	Closed	-$247K	–	1282
2020 Q4	$247K	Buy	+5,321	New	+$211K	0.04%	853
2019 Q2	–	Sell	-14,266	Closed	-$136K	–	1579
2019 Q1	$136K	Sell	14,266 -12,734	-47%	-$124K	0.01%	1298
2018 Q4	$239K	Buy	+27,000	New	+$260K	0.03%	989